Progression to Obesity: Variations in Patterns of Metabolic Fluxes, Fat Accumulation, and Gastrointestinal Responses.

Fadia Milhem, Slavko Komarnytsky
Author Information
  1. Fadia Milhem: Plants for Human Health Institute, NC State University, 600 Laureate Way, Kannapolis, NC 28081, USA.
  2. Slavko Komarnytsky: Plants for Human Health Institute, NC State University, 600 Laureate Way, Kannapolis, NC 28081, USA. ORCID

Abstract

Obesity is a multifactorial disorder that is remarkably heterogeneous. It presents itself in a variety of phenotypes that can be metabolically unhealthy or healthy, associate with no or multiple metabolic risk factors, gain extreme body weight (super-responders), as well as resist obesity despite the obesogenic environment (non-responders). Progression to obesity is ultimately linked to the overall net energy balance and activity of different metabolic fluxes. This is particularly evident from variations in fatty acids oxidation, metabolic fluxes through the pyruvate-phosphoenolpyruvate-oxaloacetate node, and extracellular accumulation of Krebs cycle metabolites, such as citrate. Patterns of fat accumulation with a focus on visceral and ectopic adipose tissue, microbiome composition, and the immune status of the gastrointestinal tract have emerged as the most promising targets that allow personalization of obesity and warrant further investigations into the critical issue of a wider and long-term weight control. Advances in understanding the biochemistry mechanisms underlying the heterogenous obesity phenotypes are critical to the development of targeted strategies to maintain healthy weight.

Keywords

References

  1. Mol Cancer. 2021 Feb 5;20(1):28 [PMID: 33546704]
  2. Am J Med. 2014 Aug;127(8):717-727.e12 [PMID: 24631411]
  3. Am J Clin Nutr. 1958 Sep-Oct;6(5):542-6 [PMID: 13594881]
  4. Obes Res. 2005 Dec;13(12):2139-45 [PMID: 16421348]
  5. Nature. 2006 Dec 14;444(7121):860-7 [PMID: 17167474]
  6. Nutr J. 2013 Jun 06;12:72 [PMID: 23742678]
  7. Circulation. 2018 Mar 27;137(13):1391-1406 [PMID: 29581366]
  8. Prz Gastroenterol. 2018;13(2):85-92 [PMID: 30002765]
  9. Diabetes Care. 2016 Feb;39(2):292-9 [PMID: 26681717]
  10. NCHS Data Brief. 2020 Feb;(360):1-8 [PMID: 32487284]
  11. Nature. 2006 Dec 21;444(7122):1027-31 [PMID: 17183312]
  12. Cell Metab. 2008 May;7(5):410-20 [PMID: 18460332]
  13. Biol Sex Differ. 2012 May 31;3(1):13 [PMID: 22651247]
  14. Exp Mol Med. 2022 Apr;54(4):358-369 [PMID: 35301430]
  15. Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):979-84 [PMID: 17210919]
  16. Am J Clin Nutr. 1995 Apr;61(4 Suppl):952S-959S [PMID: 7900694]
  17. Obesity (Silver Spring). 2007 Jun;15(6):1373-83 [PMID: 17557973]
  18. Ageing Res Rev. 2009 Oct;8(4):339-48 [PMID: 19576300]
  19. Obesity (Silver Spring). 2021 Apr;29(4):662-671 [PMID: 33759389]
  20. Int J Mol Sci. 2014 Apr 11;15(4):6184-223 [PMID: 24733068]
  21. Obes Facts. 2017;10(3):207-215 [PMID: 28564650]
  22. Int J Obes Relat Metab Disord. 1993 Dec;17 Suppl 3:S28-31; discussion S41-2 [PMID: 8124397]
  23. Diabetologia. 2007 Mar;50(3):538-44 [PMID: 17221212]
  24. Peptides. 2016 Mar;77:54-9 [PMID: 25934163]
  25. Int J Mol Sci. 2017 Feb 15;18(2): [PMID: 28212306]
  26. Am J Clin Nutr. 1998 Sep;68(3):599-606 [PMID: 9734736]
  27. Am J Med. 1998 Aug;105(2):145-50 [PMID: 9727822]
  28. Int J Obes Relat Metab Disord. 2002 Sep;26 Suppl 2:S12-7 [PMID: 12174324]
  29. Diabetes. 2010 Jul;59(7):1657-66 [PMID: 20413511]
  30. N Engl J Med. 2015 Mar 5;372(10):973-4 [PMID: 25738675]
  31. Science. 2002 May 31;296(5573):1634-5 [PMID: 12040173]
  32. BMC Med. 2019 Nov 25;17(1):212 [PMID: 31760948]
  33. Br J Nutr. 1994 Oct;72(4):619-43 [PMID: 7986792]
  34. Annu Rev Food Sci Technol. 2022 Mar 25;13:239-261 [PMID: 34813357]
  35. J Acad Nutr Diet. 2015 Aug;115(8):1203-12 [PMID: 25857868]
  36. Econ Hum Biol. 2014 Jul;14:33-49 [PMID: 24958452]
  37. Physiol Behav. 2015 Dec 1;152(Pt B):340-6 [PMID: 26188141]
  38. Cancer Epidemiol. 2015 Dec;39 Suppl 1:S34-45 [PMID: 26205840]
  39. Eur J Clin Nutr. 2006 Jan;60(1):48-57 [PMID: 16132057]
  40. Nat Rev Dis Primers. 2017 Jun 15;3:17034 [PMID: 28617414]
  41. Clin Chem. 2013 Apr;59(4):617-28 [PMID: 23401286]
  42. Eur J Clin Invest. 1991 Aug;21(4):398-405 [PMID: 1936107]
  43. Int J Obes (Lond). 2014 Mar;38(3):417-22 [PMID: 23835594]
  44. N Engl J Med. 2017 Jul 6;377(1):13-27 [PMID: 28604169]
  45. Age (Dordr). 2016 Feb;38(1):23 [PMID: 26846415]
  46. JAMA. 2016 Jun 7;315(21):2284-91 [PMID: 27272580]
  47. Diabetologia. 2022 Oct;65(10):1710-1720 [PMID: 35871650]
  48. Eur J Clin Nutr. 2008 Oct;62(10):1208-14 [PMID: 17622259]
  49. Sci Rep. 2019 Nov 21;9(1):17315 [PMID: 31754142]
  50. Int J Obes Relat Metab Disord. 2000 Feb;24(2):226-31 [PMID: 10702775]
  51. PLoS One. 2016 Jan 27;11(1):e0145074 [PMID: 26815199]
  52. J Clin Invest. 2021 Dec 15;131(24): [PMID: 34907907]
  53. Nutrients. 2018 Nov 01;10(11): [PMID: 30388849]
  54. Lancet. 2011 Aug 27;378(9793):826-37 [PMID: 21872751]
  55. J Obes Metab Syndr. 2020 Mar 30;29(1):18-25 [PMID: 32146733]
  56. Nutr Rev. 2011 Feb;69(2):99-106 [PMID: 21294743]
  57. Diabetes Care. 2014 Oct;37(10):2789-97 [PMID: 25011943]
  58. J Nutr. 1997 Sep;127(9):1875S-1883S [PMID: 9278574]
  59. JAMA. 1994 Jun 8;271(22):1747-51 [PMID: 8196117]
  60. Nutrients. 2021 Oct 05;13(10): [PMID: 34684509]
  61. Curr Opin Clin Nutr Metab Care. 2018 Sep;21(5):360-365 [PMID: 29916924]
  62. Obesity (Silver Spring). 2015 Nov;23(11):2216-22 [PMID: 26373701]
  63. Am J Clin Nutr. 2013 Oct;98(4):917-23 [PMID: 23985804]
  64. Nutr Rev. 1998 Dec;56(12):347-53 [PMID: 9884582]
  65. Curr Oncol Rep. 2016 Jul;18(7):45 [PMID: 27255389]
  66. Nat Rev Endocrinol. 2015 Aug;11(8):489-501 [PMID: 26122319]
  67. Diabetes Care. 2001 Apr;24(4):710-9 [PMID: 11315836]
  68. Appetite. 1996 Apr;26(2):153-74 [PMID: 8737167]
  69. Nutrients. 2016 Mar 14;8(3):164 [PMID: 26985905]
  70. J Biol Chem. 2003 Aug 15;278(33):30413-6 [PMID: 12788931]
  71. Ann Med. 2012 Feb;44(1):82-92 [PMID: 20964583]
  72. Rev Endocr Metab Disord. 2013 Sep;14(3):219-27 [PMID: 23928851]
  73. Surg Radiol Anat. 2010 Nov;32(9):879-82 [PMID: 20607260]
  74. Proc Nutr Soc. 1995 Mar;54(1):253-65 [PMID: 7568258]
  75. J Lipid Res. 2019 Oct;60(10):1710-1719 [PMID: 30097511]
  76. J Nutr. 2020 Sep 1;150(9):2235-2238 [PMID: 32652038]
  77. J Clin Invest. 2007 Sep;117(9):2621-37 [PMID: 17717599]
  78. J Clin Endocrinol Metab. 2007 Mar;92(3):895-901 [PMID: 17192296]
  79. Nutrients. 2022 Dec 27;15(1): [PMID: 36615781]
  80. Genome Med. 2016 Apr 27;8(1):51 [PMID: 27122046]
  81. Biochim Biophys Acta. 2015 May;1851(5):686-96 [PMID: 25668679]
  82. Obesity (Silver Spring). 2021 Oct;29(10):1582-1595 [PMID: 34464025]
  83. Gastroenterology. 2014 Nov;147(5):1055-63.e8 [PMID: 25046162]
  84. Clin Nutr. 2022 Oct;41(10):2264-2274 [PMID: 36084360]
  85. Nat Rev Endocrinol. 2019 May;15(5):288-298 [PMID: 30814686]
  86. Clin Nutr. 2005 Dec;24(6):885-95 [PMID: 16039759]
  87. PLoS One. 2014 Jan 15;9(1):e83498 [PMID: 24454704]
  88. Front Immunol. 2020 Aug 28;11:1827 [PMID: 32983093]
  89. BMC Public Health. 2020 May 19;20(1):726 [PMID: 32429951]
  90. Curr Nutr Rep. 2023 Mar;12(1):151-166 [PMID: 36738429]
  91. Mol Cell Biol. 2015 May;35(10):1686-99 [PMID: 25733684]
  92. Am J Clin Nutr. 1979 Jan;32(1):164-72 [PMID: 760499]
  93. Int J Obes (Lond). 2016 Apr;40(4):639-45 [PMID: 26499444]
  94. Physiol Rev. 1997 Jul;77(3):731-58 [PMID: 9234964]
  95. Nature. 2017 Nov 2;551(7678):115-118 [PMID: 29045397]
  96. Perspect Psychol Sci. 2017 Sep;12(5):703-714 [PMID: 28657838]
  97. Nat Commun. 2016 Oct 06;7:12977 [PMID: 27708333]
  98. Nat Rev Microbiol. 2013 Jul;11(7):497-504 [PMID: 23748339]
  99. Nature. 2019 Apr;568(7753):499-504 [PMID: 30745586]
  100. Int J Obes Relat Metab Disord. 2004 Jan;28(1):105-12 [PMID: 14647181]
  101. Adv Nutr. 2015 Sep 15;6(5):592-9 [PMID: 26374181]
  102. J Am Heart Assoc. 2021 Feb 16;10(4):e018799 [PMID: 33563002]
  103. J Multidiscip Healthc. 2021 Jun 22;14:1533-1541 [PMID: 34188480]
  104. Eur Rev Med Pharmacol Sci. 2017 Jan;21(2):329-345 [PMID: 28165552]
  105. Rev Endocr Metab Disord. 2023 Oct;24(5):901-919 [PMID: 37358728]
  106. Neurosci Biobehav Rev. 1996;20(1):119-31 [PMID: 8622818]
  107. Front Immunol. 2018 Feb 05;9:141 [PMID: 29459863]
  108. Cell Death Differ. 2020 Jul;27(7):2143-2157 [PMID: 31959914]
  109. J Clin Invest. 2005 Jul;115(7):1699-702 [PMID: 16007246]
  110. J Immunol Res. 2018 Dec 16;2018:2645465 [PMID: 30648119]
  111. Nutrients. 2019 Mar 20;11(3): [PMID: 30897855]
  112. Clin Endocrinol Metab. 1976 Jul;5(2):397-415 [PMID: 182420]
  113. Curr Obes Rep. 2018 Dec;7(4):276-288 [PMID: 30155850]
  114. Biochem J. 2008 Aug 1;413(3):369-87 [PMID: 18613815]
  115. JAMA. 2012 Sep 19;308(11):1150-9 [PMID: 22990274]
  116. Physiol Behav. 1995 May;57(5):995-1000 [PMID: 7610155]
  117. Int J Obes (Lond). 2021 Sep;45(9):2048-2057 [PMID: 34127804]
  118. Lancet. 2017 Dec 16;390(10113):2627-2642 [PMID: 29029897]
  119. Proc Nutr Soc. 2022 Mar;81(1):1-11 [PMID: 34726148]
  120. Cancer Causes Control. 2017 Mar;28(3):247-258 [PMID: 28210884]
  121. Am J Clin Nutr. 2008 Dec;88(6):1504-10 [PMID: 19064509]
  122. Biochim Biophys Acta. 2010 Mar;1801(3):338-49 [PMID: 20056169]
  123. J Phys Act Health. 2016 Feb;13(2):121-30 [PMID: 27029324]
  124. Epidemiol Health. 2020;42:e2020040 [PMID: 32512659]
  125. Diabetologia. 2013 Jul;56(7):1623-8 [PMID: 23595247]
  126. Appetite. 2009 Aug;53(1):9-15 [PMID: 19446587]
  127. Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72 [PMID: 26606383]
  128. Obes Rev. 2016 Aug;17(8):664-90 [PMID: 27213481]
  129. J Agric Food Chem. 2022 Feb 23;70(7):2077-2091 [PMID: 35147422]

Grants

  1. 1023927/United States Department of Agriculture
  2. 17022020/University of Petra, Jordan

Word Cloud

Created with Highcharts 10.0.0metabolicobesityweightphenotypeshealthygainProgressionfluxesoxidationaccumulationPatternscriticalObesitymultifactorialdisorderremarkablyheterogeneouspresentsvarietycanmetabolicallyunhealthyassociatemultipleriskfactorsextremebodysuper-responderswellresistdespiteobesogenicenvironmentnon-respondersultimatelylinkedoverallnetenergybalanceactivitydifferentparticularlyevidentvariationsfattyacidspyruvate-phosphoenolpyruvate-oxaloacetatenodeextracellularKrebscyclemetabolitescitratefatfocusvisceralectopicadiposetissuemicrobiomecompositionimmunestatusgastrointestinaltractemergedpromisingtargetsallowpersonalizationwarrantinvestigationsissuewiderlong-termcontrolAdvancesunderstandingbiochemistrymechanismsunderlyingheterogenousdevelopmenttargetedstrategiesmaintainObesity:VariationsMetabolicFluxesFatAccumulationGastrointestinalResponsesdietaryhigh-fatdietlipidinflexibilityrateobesity-proneobesity-resistant

Similar Articles

Cited By